Clinical Trial Update: Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 clinical trial evaluating the initial combination of bosentan and iloprost for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)
• Iloprost (iloprost)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: UNKNOWN